Medicare, fair prices

5.3 Million Medicare Users to Benefit From New Drug Price Negotiations
The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic and Wegovy.
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
How Medicare Says It Arrives At ‘Fair’ Prescription Drug Prices
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it selected for negotiation.
Could the Trump Administration Change the Medicare Drug Price Negotiation Program?
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be made and what changes they would like to see.
Trump's High-Stakes Meeting with Big Pharma: A Game-Changer for Drug Pricing?
President Donald Trump will meet with major drugmakers' executives to discuss drug pricing and insurance changes. Key topics include Medicare price negotiations, pharmacy benefit management, and potential tariffs on pharmaceuticals.
Trump to Meet Pharma Leaders as They Seek Drug Policy Changes
The industry is also pushing for curbs on the rebates they pay pharmacy benefit managers, which act as middlemen between drug companies and consumers, in exchange for favorable pl
Trump’s Justice Department defends Medicare drug price talks in case brought by Novartis
The court filing was made in a case brought by Novartis, one of nearly a dozen large pharmaceutical companies that have filed lawsuits challenging Medicare negotiations even as the effort proceeds. As with the other drugmakers,
Trump to Meet Pharma CEOs to Discuss Drug Pricing, Tariffs, and Medicare Negotiations
U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy benefit managers (PBMs),
Medicare Drug Coverage Is Often Inadequate—Here’s Why
She learned that she would have to try, and "fail," on two other drugs before Medicare would cover the new one.
ConsumerAffairs1d
Medicare patients facing higher drug costs
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
Medicare beneficiaries face much higher drug costs as plans quickly shift to co-insurance
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...
Here are 7 Medicare changes for 2025 that you should know about
Medicare is big business. It changes a little or a lot every year, and millions have strong opinions about it.
News Medical on MSN2d
Medicare Part D beneficiaries face rising out-of-pocket costs for brand name drugs The Expe...
Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...
RFK Jr. Now Heads HHS: How Medicare and Your Retirement May Change
Robert F. Kennedy, Jr. was confirmed today to head up Medicare. Here are five ways his leadership might change your ...